DUBLIN, Dec 21, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Insulin Delivery Devices Market 2014 - 2025" report to their offering.
The insulin delivery devices market is expected to reach USD 19.8 billion by 2025. The global industry is estimated to witness a high growth during the forecast period from 2016 to 2025. Rapidly increasing number of diabetics coupled with the escalating attention around diabetes care is a major factor propelling the market.
The insulin pens segment was the largest revenue-generating category of this market in 2015. The pen is equipped with self-contained cartridges and offers ease in handling & less pain while injecting insulin. Advantages of these pen devices over other products are resulting in its growing popularity, thus serving as a vital factor in contributing to the sector's highest share in this market.
Homecare is estimated to be the largest shareholder and the fastest growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients.
North America is the leading regional sector and accounted for the largest revenue share in 2015 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting the market growth.
The Asia Pacific region is anticipated to be the fastest growing market during the forecast period. The high prevalence rate of diabetes in the Asian countries, such as China and India, is a major factor contributing to market expansion in this region.
- Novo Nordisk A/S
- Eli Lilly and Company
- Biocon Ltd.
- Ypsomed AG
- Wockhardt Ltd.
- Abbott Laboratories
- F. Hoffmann-La Roche, Ltd.
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Market Variables, Trends & Scope
4. Market Categorization 1: Product Estimates & Trend Analysis
5. Market Categorization 2: By End-Use, Estimates & Trend Analysis
6. Market Categorization 5: Regional Estimates & Trend Analysis
7. Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/l9n3jf/insulin_delivery
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets